Listen Now
Topics Covered
- Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19
- Staging & Grading
- Current Standard of Care
- Treatment Options for Resistant Disease
- Emerging Treatment Approaches
- Updates on Clinical Trials
- How Research Contributes to Treatment Options
- Tips to Manage Side Effects & Discomfort
- Key Questions to Ask Your Health Care Team
- Follow-Up Care: What to Expect
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of Questions
- Questions for Our Panel of Experts
Our Panel of Experts
Sarah C. Rutherford, MD
John P. Leonard, MD/Gwirtzman Family Research Scholar in Lymphoma, Assistant Professor of Medicine, Weill Cornell Medical College, Cornell University
Catherine S M Diefenbach, MD
Associate Professor of Medicine, Translational Director of Hematology, Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-Designated Comprehensive Cancer Center, NYU Langone Health
Adolfo Enrique Diaz, MD, MSc
Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center
Belita Cowan, MA
President, Lymphoma Foundation of America
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
(112 KB)
Workshop Date
This workshop was originally recorded on May 12, 2021.